Vorolanib Uses, Dosage, Side Effects and more

Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).

Trade Name Vorolanib
Generic Vorolanib
Vorolanib Other Names Vorolanib
Type
Formula C23H26FN5O3
Weight Average: 439.491
Monoisotopic: 439.20196788
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share